Abstract
Background: Radiation therapy for locally advanced cervix cancer (laCC) includes external beam radiotherapy (EBRT) followed by brachytherapy (BT). A total combined EQD2 dose of ≥85 Gray (Gy) to 90% of the high-risk clinical target volume (HRCTV D90) has been shown to improve local control and disease outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
